DVA:NYE-DaVita Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 133.51

Change

0.00 (0.00)%

Market Cap

USD 12.45B

Volume

0.48M

Analyst Target

USD 97.80
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

DaVita Inc, formerly DaVita HealthCare Partners Inc operates kidney dialysis centers and provides related lab services in dialysis centers and in contracted hospitals across USA. It also operates other ancillary services and strategic initiatives.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+0.25 (+0.07%)

USD 105.82B
UHS Universal Health Services Inc

+1.58 (+0.77%)

USD 15.62B
THC Tenet Healthcare Corporation

-4.68 (-2.88%)

USD 15.10B
EHC Encompass Health Corp

+1.34 (+1.34%)

USD 9.63B
CHE Chemed Corp

-74.00 (-12.14%)

USD 9.04B
CON Concentra Group Holdings Paren..

+0.56 (+2.77%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

-0.23 (-1.23%)

USD 2.59B
NHC National HealthCare Corporatio..

-3.06 (-2.51%)

USD 1.83B
AMN AMN Healthcare Services Inc

-1.10 (-2.71%)

USD 1.54B
BKD Brookdale Senior Living Inc

+0.07 (+1.12%)

USD 1.26B

ETFs Containing DVA

SANE 4.09 % 0.00 %

N/A

N/A
BOUT Innovator ETFs Trust - In.. 3.39 % 0.80 %

-0.23 (0%)

USD 0.01B
FHH:CA First Trust AlphaDEX US H.. 2.45 % 0.77 %

+0.30 (+0%)

CAD 0.01B
FHH-F:CA First Trust AlphaDEX U.S... 2.45 % 0.00 %

N/A

CAD 0.01B
FXH First Trust Health Care A.. 2.26 % 0.63 %

+0.33 (+0%)

USD 1.18B
XLVE:CA Mulvihill U.S. Health Car.. 1.78 % 0.00 %

-0.02 (0%)

N/A
JPLG:LSE JPM Global Equity Multi-F.. 0.34 % 0.00 %

-2.25 (0%)

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
PHB Invesco Fundamental High .. 0.00 % 0.50 %

-0.04 (0%)

N/A
BACK:LSE 0.00 % 0.00 %

N/A

N/A
SLIM 0.00 % 0.50 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 27.44% 83% B 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.44% 83% B 95% A
Trailing 12 Months  
Capital Gain 47.75% 87% B+ 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.75% 87% B+ 91% A-
Trailing 5 Years  
Capital Gain 141.69% 93% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 141.69% 87% B+ 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 17.65% 78% C+ 82% B
Dividend Return 17.65% 78% C+ 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 33.93% 61% D- 32% F
Risk Adjusted Return 52.02% 87% B+ 76% C+
Market Capitalization 12.45B 92% A 86% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.10 47% 47%
Price/Book Ratio 11.05 14% 7%
Price / Cash Flow Ratio 5.65 58% 57%
Price/Free Cash Flow Ratio 9.65 50% 44%
Management Effectiveness  
Return on Equity 38.53% 95% 94%
Return on Invested Capital 14.47% 92% 77%
Return on Assets 5.92% 79% 78%
Debt to Equity Ratio 782.91% 18% 4%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector